MedPath

CARDIOVASCULAR RESEARCH FOUNDATION

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

THT 2025 Conference to Showcase Groundbreaking Heart Failure Clinical Trials

The Cardiovascular Research Foundation's Technology & Heart Failure Therapeutics (THT) 2025 conference will feature multiple late-breaking clinical trials across four dedicated sessions.

TCT 2024 to Showcase Groundbreaking Cardiovascular Research

TCT 2024 will feature 25 late-breaking clinical trials, presenting novel interventions, drugs, and techniques for cardiovascular disease treatment.

Philips Launches DEFINE GPS Trial to Evaluate iFR-Guided PCI for Superior Outcomes

Philips has enrolled the first patient in the DEFINE GPS trial, a global study investigating if iFR measurements co-registered on angiograms improve outcomes in coronary interventions compared to standard angiography alone.

© Copyright 2025. All Rights Reserved by MedPath